Literature DB >> 3259254

In vitro cellular tropism of human B-lymphotropic virus (human herpesvirus-6).

P Lusso1, P D Markham, E Tschachler, F di Marzo Veronese, S Z Salahuddin, D V Ablashi, S Pahwa, K Krohn, R C Gallo.   

Abstract

We investigated the cellular tropism of human B-lymphotropic virus (HBLV) (also designated Human Herpesvirus-6) in vitro by infecting fresh MN cells from normal human adult peripheral blood, umbilical cord blood, bone marrow, tonsil, and thymus. Cultures from all the sources examined contained infectable cells, as shown by the appearance of characteristic enlarged, round-shaped, short-lived cells expressing HBLV-specific markers. Detailed immunological analysis demonstrated that the vast majority of these cells expressed T cell-associated antigens (i.e., CD7, CD5, CD2, CD4, and to a lesser extent, CD8). The CD3 antigen and the TCR-alpha/beta heterodimer were not detectable on the surface membrane, but were identified within the cytoplasm of HBLV-infected cells, by both immunofluorescence and radioimmunoprecipitation assay. A proportion of the HBLV-infected cell population also expressed the CD15 and class II MHC DR antigens. By means of immunoselection procedures it was possible to show that a consistent proportion of HBLV-infectable cells were contained within the CD3-depleted immature T cell population, while the depletion of CD2+ cells completely abrogated the infectability of the cultures. Northern blot analysis confirmed the T cell origin of HBLV-infected cells, demonstrating the expression of full size TCR-alpha and -beta chain mRNA. In addition to fresh T cells, HBLV was able to infect normal T lymphocytes expanded in vitro with IL-2 for greater than 30 d. These results indicate that HBLV is selectively T cell tropic in the course of the in vitro infection of normal mononuclear cells and may therefore be directly involved in the pathogenesis of T cell related hematological disorders. In particular, in light of the cytopathic effect exerted in vitro on CD4+ T lymphocytes, a possible role of HBLV in immune deficiency conditions should be considered.

Entities:  

Mesh:

Year:  1988        PMID: 3259254      PMCID: PMC2188940          DOI: 10.1084/jem.167.5.1659

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  20 in total

1.  Ultrastructural characterization of a new human B lymphotropic DNA virus (human herpesvirus 6) isolated from patients with lymphoproliferative disease.

Authors:  P Biberfeld; B Kramarsky; S Z Salahuddin; R C Gallo
Journal:  J Natl Cancer Inst       Date:  1987-11       Impact factor: 13.506

2.  Characteristics of a monoclonal antibody (WT-31) that recognizes a common epitope on the human T cell receptor for antigen.

Authors:  H Spits; J Borst; W Tax; P J Capel; C Terhorst; J E de Vries
Journal:  J Immunol       Date:  1985-09       Impact factor: 5.422

3.  Developmental regulation of T-cell receptor gene expression.

Authors:  D H Raulet; R D Garman; H Saito; S Tonegawa
Journal:  Nature       Date:  1985 Mar 7-13       Impact factor: 49.962

4.  Immunofluorescent studies of the development of pre-B cells, B lymphocytes and immunoglobulin isotype diversity in humans.

Authors:  W E Gathings; A R Lawton; M D Cooper
Journal:  Eur J Immunol       Date:  1977-11       Impact factor: 5.532

5.  Magnetic monosized polymer particles for fast and specific fractionation of human mononuclear cells.

Authors:  T Lea; F Vartdal; C Davies; J Ugelstad
Journal:  Scand J Immunol       Date:  1985-08       Impact factor: 3.487

6.  The human T cell receptor: appearance in ontogeny and biochemical relationship of alpha and beta subunits on IL-2 dependent clones and T cell tumors.

Authors:  O Acuto; R E Hussey; K A Fitzgerald; J P Protentis; S C Meuer; S F Schlossman; E L Reinherz
Journal:  Cell       Date:  1983-10       Impact factor: 41.582

7.  Pathogenesis of B cell lymphoma in a patient with AIDS.

Authors:  J E Groopman; J L Sullivan; C Mulder; D Ginsburg; S H Orkin; C J O'Hara; K Falchuk; F Wong-Staal; R C Gallo
Journal:  Blood       Date:  1986-03       Impact factor: 22.113

8.  Leu-M1 antigen expression in T-cell neoplasia.

Authors:  R Wieczorek; J S Burke; D M Knowles
Journal:  Am J Pathol       Date:  1985-12       Impact factor: 4.307

9.  Discrete stages of human intrathymic differentiation: analysis of normal thymocytes and leukemic lymphoblasts of T-cell lineage.

Authors:  E L Reinherz; P C Kung; G Goldstein; R H Levey; S F Schlossman
Journal:  Proc Natl Acad Sci U S A       Date:  1980-03       Impact factor: 11.205

10.  Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders.

Authors:  S Z Salahuddin; D V Ablashi; P D Markham; S F Josephs; S Sturzenegger; M Kaplan; G Halligan; P Biberfeld; F Wong-Staal; B Kramarsky
Journal:  Science       Date:  1986-10-31       Impact factor: 47.728

View more
  94 in total

Review 1.  Human herpesvirus 6.

Authors:  D K Braun; G Dominguez; P E Pellett
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

2.  Viral gene expression patterns in human herpesvirus 6B-infected T cells.

Authors:  Bodil Øster; Per Höllsberg
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

3.  Pneumonitis associated with coinfection by human herpesvirus 6 and Legionella in an immunocompetent adult.

Authors:  S K Russler; M A Tapper; K K Knox; A Liepins; D R Carrigan
Journal:  Am J Pathol       Date:  1991-06       Impact factor: 4.307

Review 4.  Viral modulation of T-cell receptor signaling.

Authors:  Keith R Jerome
Journal:  J Virol       Date:  2008-02-20       Impact factor: 5.103

5.  Human herpesvirus 6 and Epstein-Barr virus in Hodgkin's disease: a controlled study by polymerase chain reaction and in situ hybridization.

Authors:  G Valente; P Secchiero; P Lusso; M C Abete; C Jemma; G Reato; S Kerim; R C Gallo; G Palestro
Journal:  Am J Pathol       Date:  1996-11       Impact factor: 4.307

6.  The U24 protein from human herpesvirus 6 and 7 affects endocytic recycling.

Authors:  Brian M Sullivan; Laurent Coscoy
Journal:  J Virol       Date:  2009-11-18       Impact factor: 5.103

7.  Expression of human herpesvirus-6 antigens in benign and malignant lymphoproliferative diseases.

Authors:  M Luppi; P Barozzi; R Garber; A Maiorana; G Bonacorsi; T Artusi; R Trovato; R Marasca; G Torelli
Journal:  Am J Pathol       Date:  1998-09       Impact factor: 4.307

8.  Establishment of titration system for human herpesvirus 6 and evaluation of neutralizing antibody response to the virus.

Authors:  H Asada; S Yalcin; K Balachandra; K Higashi; K Yamanishi
Journal:  J Clin Microbiol       Date:  1989-10       Impact factor: 5.948

9.  Detection by polymerase chain reaction amplification of human herpesvirus 6 DNA in peripheral blood of patients with exanthem subitum.

Authors:  K Kondo; Y Hayakawa; H Mori; S Sato; T Kondo; K Takahashi; Y Minamishima; M Takahashi; K Yamanishi
Journal:  J Clin Microbiol       Date:  1990-05       Impact factor: 5.948

10.  Human herpesvirus 6 open reading frame U12 encodes a functional beta-chemokine receptor.

Authors:  Y Isegawa; Z Ping; K Nakano; N Sugimoto; K Yamanishi
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.